FDCPs: generally BE (higher BA under certain conditions) [Regulatives / Guidelines]

posted by Mauricio Sampaio  – Brazil, 2016-05-19 07:47 (3686 d 11:36 ago) – Posting: # 16331
Views: 3,949

Thinking about a new Fixed Dose combination of two inhalers drugs in a same capsule, should be conducted tests to elucidate any pharmacokinetic or pharmacodynamic interaction between the actives as well as?

Until the moment, I was thinking that all interactions studies are used to predict interactions in drugs administrated by oral which metabolic effects can be observed.

:confused::confused::confused::confused:

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
128 visitors (0 registered, 128 guests [including 27 identified bots]).
Forum time: 19:24 CEST (Europe/Vienna)

Scientists cannot simply hang their subjectivities
up on a hook outside the laboratory door.    Ruth Bleier

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5